SCHEMBL543403

SCHEMBL543403

NC(=O)C=CC1CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL730203 1.00 HDAC2 (0.34)
SCHEMBL6360578 0.91 EPHX2 (0.33)
SCHEMBL532572 0.90 GRIN1 (0.39)
SCHEMBL4743867 0.90
SCHEMBL163417 0.87 GRIN1 (0.41)
SCHEMBL3114037 0.87 GRIN1 (0.41)
SCHEMBL4079497 0.87 GRIN1 (0.41)
SCHEMBL3260263 0.84 TSHR (0.38)
SCHEMBL3260266 0.84 TSHR (0.38)
SCHEMBL2467976 0.83 L3MBTL3 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 133 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021081241-A1 REVERSIBLE ADHESIVES ALFRED E. MANN INSTITUTE FOR BIOMEDICAL ENGINEERING AT THE UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2021-04-29 WO claimed
CN-109350847-A A kind of functionalization implanted flexible electrode and its application 深圳先进技术研究院 2019-02-19 CN claimed
CN-103534258-B Tyrosine kinase inhibitor 普林斯匹亚生物制药公司 2016-09-14 CN claimed
EP-2861599-A1 REVERSIBLE COVALENT PYRROLO- OR PYRAZOLOPYRIMIDINES USEFUL FOR THE TREATMENT CANCER AND AUTOIMMUNE DISEASES Principia Biopharma Inc. (US) 2015-04-22 EP claimed
WO-2013191965-A1 REVERSIBLE COVALENT PYRROLO- OR PYRAZOLOPYRIMIDINES USEFUL FOR THE TREATMENT CANCER AND AUTOIMMUNE DISEASES PRINCIPIA BIOPHARMA INC. (US) 2013-12-27 WO claimed
WO-2012178071-A9 DEVICE AND METHODS FOR TEMPERATURE AND HUMIDITY MEASUREMENTS USING A NANOCOMPOSITE FILM SENSOR BROWN UNIVERSITY (US) 2013-02-21 WO claimed
WO-2012178071-A2 DEVICE AND METHODS FOR TEMPERATURE AND HUMIDITY MEASUREMENTS USING A NANOCOMPOSITE FILM SENSOR BROWN UNIVERSITY (US) 2012-12-27 WO claimed
WO-2006014524-A2 MEDICAL DEVICE WITH LOW MAGNETIC SUSCEPTIBILITY NANOSET, LLC (US) 2006-02-09 WO claimed
EP-1226438-A1 COMPOSITE NANOSPHERES AND THEIR CONJUGATES WITH BIOMOLECULES BIO MERIEUX (FR) 2002-07-31 EP claimed
WO-2001052979-A1 METHOD FOR PREPARING STABLE AND FUNCTIONALISED COLLOIDAL PARTICLES AND RESULTING PARTICULATE REAGENT BIO MERIEUX (FR) 2001-07-26 WO claimed
WO-2001033223-A1 COMPOSITE NANOSPHERES AND THEIR CONJUGATES WITH BIOMOLECULES BIO MERIEUX (FR) 2001-05-10 WO claimed
EP-0767812-A1 SUPERABSORBENT FOAMS, AND METHOD FOR PRODUCING THE SAME UNIVERSITY OF CINCINNATI (US) 1997-04-16 EP claimed
US-5573994-A CROSSLINKING POLYMER, PHASE SEPARATION UNIVERSITY OF CINCINNATI (US) 1996-11-12 US claimed
WO-1995031500-A2 SUPERABSORBENT FOAMS, AND METHOD FOR PRODUCING THE SAME UNIVERSITY OF CINCINNATI (US) 1995-11-23 WO claimed
US-12606699-B2 Polymer composite, rubber composition, and tire SUMITOMO RUBBER INDUSTRIES, LTD. (JP) 2026-04-21 US disclosed
EP-4245565-B1 TIRE SUMITOMO RUBBER IND (JP) 2025-07-23 EP disclosed
EP-3990272-B1 ULTRASONIC COUPLING DEVICE SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) 2025-05-07 EP disclosed
EP-0533573-A2 Derivatives of 3-cyclo alkyl-propen-2-amide, their tautomeres and salts and their use as antiinflammatory agents ROUSSEL UCLAF (FR) 1993-03-24 EP disclosed
US-4927826-A Cycloproylpropenamides useful as platelet activing factor (PAF) antagonists HOFFMAN-LA ROCHE INC. (US) 1990-05-22 US disclosed
US-4786646-A PLATELET ACTIVATING FACTOR ANTAGONISTS HOFFMANN-LA ROCHE INC. (US) 1988-11-22 US disclosed